NCT04615000View on ClinicalTrials.gov

SeroCovid<19: Covid-19 Seroconversion in Tertiary Pediatric Patients

CompletedOBSERVATIONAL
Enrollment

362

Participants

Timeline

Start Date

October 29, 2020

Primary Completion Date

November 1, 2021

Study Completion Date

November 1, 2021

Conditions
Covid19Children, Only
Interventions
DIAGNOSTIC_TEST

SARS-CoV-2 serological assessment (IgG)

Periodic assessment of the serology status (SARS-CoV-2 specific IgG) with a 3 to 6 month interval

Trial Locations (1)

9000

Ghent University Hospital, Ghent

All Listed Sponsors
collaborator

University Ghent

OTHER

lead

University Hospital, Ghent

OTHER

NCT04615000 - SeroCovid<19: Covid-19 Seroconversion in Tertiary Pediatric Patients | Biotech Hunter | Biotech Hunter